$1.09
4.39% yesterday
Nasdaq, Jun 06, 10:17 pm CET
ISIN
US42328V5049
Symbol
HSDT

Helius Medical Technologies Inc Class A Stock price

$1.09
-3.29 75.11% 1M
-7.91 87.89% 6M
-8.96 89.16% YTD
-16.91 93.94% 1Y
-18,373.91 99.99% 5Y
-287,436.41 100.00% 10Y
-283,787.66 100.00% 20Y
Nasdaq, Closing price Fri, Jun 06 2025
-0.05 4.39%
ISIN
US42328V5049
Symbol
HSDT
Sector

Key metrics

Market capitalization $580.00k
Enterprise Value $-530.00k
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.05
EV/Sales (TTM) EV/Sales -1.24
P/S ratio (TTM) P/S ratio 1.34
P/B ratio (TTM) P/B ratio 0.35
Revenue growth (TTM) Revenue growth 4.88%
Revenue (TTM) Revenue $430.00k
EBIT (operating result TTM) EBIT $-14.50m
Free Cash Flow (TTM) Free Cash Flow $-11.58m
Cash position $1.11m
EPS (TTM) EPS $-25.93
P/E forward negative
P/S forward 1.14
EV/Sales forward negative
Short interest 1.47%
Show more

Is Helius Medical Technologies Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

Helius Medical Technologies Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Helius Medical Technologies Inc Class A:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Helius Medical Technologies Inc Class A:

Buy
100%

Financial data from Helius Medical Technologies Inc Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
0.43 0.43
5% 5%
100%
- Direct Costs 0.58 0.58
45% 45%
135%
-0.15 -0.15
1,600% 1,600%
-35%
- Selling and Administrative Expenses 10 10
62% 62%
2,437%
- Research and Development Expense 3.82 3.82
77% 77%
888%
-14 -14
65% 65%
-3,367%
- Depreciation and Amortization 0.02 0.02
60% 60%
5%
EBIT (Operating Income) EBIT -14 -14
64% 64%
-3,372%
Net Profit -13 -13
81% 81%
-3,037%

In millions USD.

Don't miss a Thing! We will send you all news about Helius Medical Technologies Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Helius Medical Technologies Inc Class A Stock News

Neutral
GlobeNewsWire
3 days ago
NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of its public offering of an aggregate of 2,768,600 shares of its Class A common stock (or common stock equivalents), and war...
Neutral
GlobeNewsWire
3 days ago
Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq's Equity Rule requirement Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq's Equity Rule requirement
Neutral
GlobeNewsWire
18 days ago
Shepherd Center's Dr. Deborah Backus to Showcase Final Results of PoNSTEP Study, Providing New Insight into Maximizing Impact of Neuromodulation to Improve Gait in People with MS Shepherd Center's Dr. Deborah Backus to Showcase Final Results of PoNSTEP Study, Providing New Insight into Maximizing Impact of Neuromodulation to Improve Gait in People with MS
More Helius Medical Technologies Inc Class A News

Company Profile

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.

Head office United States
CEO Dane Andreeff
Employees 21
Founded 2014
Website heliusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today